Pfizer Launches Phase III Trial For Sutent In Non-Small Cell Lung Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Positive preliminary Phase II results on sunitinib/erlotinib combination therapy were presented at major lung cancer meeting this week in South Korea.